Page 16 - Pharmaceutical M5 Biopharma

16  Sponsored Feature

Bioanalysis Accelerating the pre-clinical/clinical phase

Primer eBook: Application News: Application News:
nSMOL Improves the Speed and LCMS Bioanalysis of Antibody LCMS Bioanalysis of Antibody
Accuracy of mAb BioanalysisNano- Drugs Using Fab-Selective Drugs Using Fab-Selective
technology, limited proteolysis, and Proteolysis nSMOL Proteolysis nSMOL
LCMS analysis. Part 1 – Trastuzumab Analysis Part 2 – Bevacizumab Analysis

Application News: Application News: Application News:
LCMS Bioanalysis of Antibody LCMS Bioanalysis of Antibody LC-MS Bioanalysis of Antibody
Drugs Using Fab-Selective Drugs Using Fab-Selective Drugs Using Fab-Selective
Proteolysis nSMOL Proteolysis nSMOL Proteolysis nSMOL - Part 5 -
Part 3 – Nivolumab Analysis Part 4 – Multiplex Analysis Instrument comparison

Video: Application News: Peer-reviewed journal article:
nSMOL – How Nano LCMS Bioanalysis of Antibody Vialaret J, Broutin S, Paci A, Hirtz
Technology and LC-MS Drugs Using Fab-Selective C. et al., Bioanalysis. 2018 May
Improved Speed and Accuracy Proteolysis nSMOL 1;10(10)
of mAb Bioanalysis Part 6 – For Automated Analysis What sample preparation
should be chosen for targeted
MS monoclonal antibody
quantification in human serum?